Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Traws Pharma Logo
Traws Pharma Growth Score
64
CB Rank
40610
Heat Score
75
Traws Pharma is a clinical-stage biopharmaceutical business focused on creating best-in-class small molecule oral therapies for respiratory.
Founded
obfuscation
PublicPost-IPO Equity Newtown, Pennsylvania, United States51-100 www.trawspharma.com
Biopharma
Health Care
Medical
Overview

Traws Pharma
Total Funding
obfuscation
Growth Score
64
Heat Score
75

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score64
-6 pts
in past quarter
Heat Score 75
18 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Traws Pharma

CB Rank
40610
Traws Pharma is a clinical-stage biopharmaceutical business focused on creating best-in-class small molecule oral therapies for respiratory.
Founded
obfuscation
PublicPost-IPO Equity Newtown, Pennsylvania, United States51-100 www.trawspharma.com
Biopharma
Health Care
Medical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Traws Pharma Inc.
Also Known As Trawsfynydd Therapeutics
Operating Status Active
Stock Symbol  NASDAQ:TRAW
Company Type For Profit
About the Company
Traws Pharma is a clinical-stage biopharmaceutical business focused on creating best-in-class small molecule oral therapies for respiratory virus infections and cancers.
Phone Number +1-267-759-3680
Contact Email info@trawspharma.com
Predictions & Insights

Growth Insight

See this Growth Insight
Traws Pharma is
Lorem
 to be growing
Top Contributing Factors
Merger or Acquisition

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

TRX01 (ratutrelvir)
An investigational oral inhibitor targeting the main protease of SARS-CoV-2 for COVID-19 treatment, aiming to reduce drug interactions and improve eligibility for treatment.
TRX100 (tivoxavir marboxil)
A Cap-independent endonuclease inhibitor under development for treating and preventing pandemic influenza, effective against drug-resistant and pandemic-potential viruses.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Traws Pharma Logo
Post-IPO Equity - Traws Pharma
1
obfuscation
Sirenia Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - Traws Pharma Logo
Post-IPO Equity - Traws Pharma
1
obfuscation
Sirenia Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - Traws Pharma Logo
Post-IPO Equity - Traws Pharma
1
obfuscation
Sirenia Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - Traws Pharma Logo
Post-IPO Equity - Traws Pharma
1
obfuscation
Sirenia Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - Traws Pharma Logo
Post-IPO Equity - Traws Pharma
1
obfuscation
Sirenia Capital ManagementPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Traws Pharma Logo
Post-IPO Equity - Traws Pharma
1
obfuscation
Sirenia Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - Traws Pharma Logo
Post-IPO Equity - Traws Pharma
1
obfuscation
Sirenia Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - Traws Pharma Logo
Post-IPO Equity - Traws Pharma
1
obfuscation
Sirenia Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - Traws Pharma Logo
Post-IPO Equity - Traws Pharma
1
obfuscation
Sirenia Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - Traws Pharma Logo
Post-IPO Equity - Traws Pharma
1
obfuscation
Sirenia Capital ManagementPost-IPO Equity

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 3 Board Members and Advisors 2

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 14, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,726
-1.6%
 in past month

IT Spend

$63KThis year, Traws Pharma is projected to spend $63K on IT, according to Aberdeen.

Active Website Tech Count

4Traws Pharma is actively using 4 technologies for its website, according to BuiltWith. These include Viewport Meta, CommonCrawl Top 50m, and  DNSSEC.
Sub-Organizations
Frequently Asked Questions

Where is Traws Pharma's headquarters? Traws Pharma is located in Newtown, Pennsylvania, United States.Who invested in Traws Pharma? Traws Pharma is funded by Sirenia Capital Management.When was the last funding round for Traws Pharma? Traws Pharma closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has Traws Pharma raised to date? Traws Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|